We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Breast Cancer Treatment – Prof. Andrew Tutt on the OlympiA Trial

Video  
Published: June 14, 2021
 
| Taken from The Institute of Cancer Research, YouTube
The results of the OlympiA clinical trial, involving ICR researchers, shows giving the drug olaparib for one year to breast cancer patients with inherited BRCA mutations, after they have completed initial treatment, reduced the chance of their breast cancer returning.

Professor Andrew Tutt, Head of Breast Cancer Research at the ICR, explains more.

Related Topic Pages
Anticancer Therapies
Advertisement
Chosen for You
Infographic

Lab Sustainability
Green and white pills falling to the ground.
Article

Passage of the FDA Modernization Act Enables New Era for Preclinical Testing
Simplified world map and stick men joining hands to collaborate.
Article

Global Regulators Embrace Collaborative Initiatives
Advertisement
Advertisement
Never miss a story
with the Breaking Science News daily newsletter